Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sibling Cord Blood Infusions in Children With Cerebral Palsy
NCT02599207Phase 1Completed
- Sponsor
- Joanne Kurtzberg
- Start
- Nov 2015
- Primary completion
- Oct 2016
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 1, open-label trial of allogeneic sibling umbilical cord blood in cerebral palsy (CP) (2 arms), sponsored by Joanne Kurtzberg. Primary endpoint: Assessment for infusion reactions, infections, graft versus host disease or any other adverse events at 6 months. Started Nov 2015; status: completed.
02
Drugs
allogeneic sibling umbilical cord blood
03
Conditions
cerebral palsy (CP)
Beyond the preview
Go deeper on NCT02599207.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02599207.